News

Vectura Group is acquired by Philip Morris

Read time: 1 mins

Published:16th Aug 2021

Vectura Group PLC accepted Philip Morris International Inc's takeover bid, despite concern about the ethics of the asthma treatment firm coming under the influence of the tobacco company.

Private equity firm Carlyle Group has decided against raising its takeover offer for the FTSE 250 firm, meaning a proposed auction was cancelled. This means the Philip Morris's takeover offer of 165 pence per share, which values Vectura at GBP1.02 billion, remained the highest bid.

Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Industry news

Sanofi and Orano join forces to develop next-generation radioligand medicines.

Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines.

1 mins

Industry news

Lundbeck to acquire Longboard Pharma and with it bexicaserin anti-seizure product

H. Lundbeck A/S and Longboard Pharmaceuticals, Inc., announced an agreement for Lundbeck to acquire Longboard

1 min

Industry news

Survey commissioned by Roche of women's attitudes to screening for human papillomavirus (HPV)

Women continue to face significant barriers to accessing screening for human papillomavirus (HPV), the cause of 99% of cervical cancer cases. In a global survey commissioned by Roche

1 min

See all news